Navigation Links
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
Date:6/12/2008

ion or with underlying conditions that may predispose patients to infections.

TNF-blocking agents have been associated with reactivation of hepatitis B (HBV) in patients who are chronic carriers of the virus. Some cases have been fatal. Patients at risk for HBV infection should be evaluated for prior evidence of HBV infection before initiating HUMIRA.

The combinations of HUMIRA and anakinra as well as HUMIRA and abatacept is not recommended.

TNF antagonists, including HUMIRA, have been associated in rare cases with demyelinating disease and serious allergic reactions. Rare reports of pancytopenia including aplastic anemia have been reported with TNF-blocking agents. Adverse events of the haematologic system, including medically significant cytopenia have been infrequently reported with HUMIRA.

More cases of malignancies including lymphoma have been observed among patients receiving a TNF antagonist compared with control patients in clinical trials. The size of the control group and limited duration of the controlled portions of studies precludes the ability to draw firm conclusions. Furthermore, there is an increased background lymphoma risk in rheumatoid arthritis patients with long-standing, highly active, inflammatory disease, which complicates the risk estimation. During the long-term open-label trials with HUMIRA, the overall rate of malignancies was similar to what would be expected for an age, gender and race matched general population. With the current knowledge, a possible risk for the development of lymphomas or other malignancies in patients treated with a TNF antagonist cannot be excluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of Psoralen Ultra-Violet A (PUVA) treatment, should be examined for the presence of non- melanoma skin cancer prior to and during treatment with HUMIRA.

In clinical studies with another TNF antago
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
2. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
3. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
4. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
5. Data Show that Abbotts HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
6. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
7. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
8. Treating diabetes during pregnancy can break link to childhood obesity
9. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
10. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
11. Family-based treatment more effective than supportive psychotherapy in treating bulimia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 According to Vanessa Grigoriadis, ... called “psychonauts” are creating new designer drugs featuring psychoactive ... of published documents and patented formulas. She reported her ... Now on June 4. , “Some of these ... never tested on humans. Maybe some of them are ...
(Date:6/19/2013)... The Report "Data Center Security Market [Logical ... UTM, IAM, SIEM, DR, ILM); Physical Security (PSIM, ... Forecasts & Analysis (2013-2018)", defines and segments the ... with in-depth analysis and forecasting of revenues. It ... with insights into trends, opportunities, and challenges. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Tools4ever, a ... sponsoring today's event, at which it will be giving ... well as giving further insight into its leading-edge solutions. ... IT & business professionals specialising in IDM infrastructure and ... of markets including the public sector, banking, finance and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Recovery Associates, ... upon crystal meth addiction treatment, helping men and women ... drug. , Crystal meth is a stimulant named for ... drug is most commonly smoked, but it can also ... commonly created in homemade labs using common household ingredients ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US ... test that has been specifically designed to help a recipient ... if their blood contains elevated levels of cobalt, and chromium, ... to see how the device is doing. In the event ... explain the possible options the person will need to consider, ...
Breaking Medicine News(10 mins):Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4Health News:Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates 2Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2
... want doctors to be ready to handle medical problems and ... //In the present state, what happens when a person develops ... back to normal conditions for treatment in time simply because ... from a UF study show there is little difference in ...
... has not yet been discovered. Currently,its diagnosis means, high-dose ... the cancer – a watch and wait approach. Recently, ... Belgium explored the possibility of providing patients with continuous ... be published in the November 15, 2006, issue of ...
... to open in Bihar as two US and six Indian ... ,"The Bihar State Investment Promotion Board (SIPB) has ... private sector," said a state official on condition of anonymity. ... in the health sector," he added. ,According to ...
... policymakers to ensure equal access to treatment and livelihood ... social vulnerability., ,"It is imperative to see that ... get equal opportunities to access treatment," stated the National ... on 'Gender impact of HIV and AIDS in India', ...
... million pounds have been pledged to mental hospitals around ... for inmates. A report published early this year by// ... incidents of attempted rape and specifically mentioned 19 incidents ... has catapulted this decision from the government. ...
... Infant Death Syndrome (SIDS) or 'cot death' that kills about ... a defect in the brain, scientists have said.// ... in the US compared the brains of cot death victims ... conditions. , ,They discovered a defect in the brain ...
Cached Medicine News:Health News:Researchers explore medicine in space 2Health News:Researchers explore medicine in space 3Health News:Fighting cancer - Multiple Myeloma with long-term therapy 2Health News:Equal Opportunities For HIV-Positive Women Urged 2
(Date:6/18/2013)... Mass. , June 18, 2013 Decision Resources, ... pharmaceutical and healthcare issues, finds that, over the past 12 ... France , Germany , ... the United Kingdom ) have been required ... of their HIV patients, primarily to reduce costs. Additionally, more ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... 18, 2013 Remedy Informatics, a leading ... life sciences research, today announced it has been ... Schedule 70 supply contract (GS-35F-367AA, effective May 7, ... IT solutions to government agencies at federal, state ... Remedy has placed its products and services on ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
... ROTTERDAM, The Netherlands , July 8, 2010 , ... - Novel Platform Set to Transform Human Therapeutic ... arGEN-X, ... proprietary SIMPLE,Antibody(TM) platform, announces that it has been granted the first patent,covering the platform. ...
Cached Medicine Technology:Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 2arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: